On Monday Amsterdam is starting with the national PrEP program, a nationwide experiment in which the HIV prevention pill is prescribed to a limited number of people with a higher risk of contracting the disease. From today, up to 1,700 gay and transgender Amsterdam residents can sign up for the program through the GGD Amsterdam site.
From today GGD health institutions will start providing the HIV prevention pill PrEP and the medical care that comes with it. The pill is intended for homosexual men, who are at higher risk of contracting HIV. The GGDs expect that thousands of men will want to use PrEP, NOS reports.
The Dutch Health Council wants the government to make HIV prevention pill Prep available to population groups that are at higher risk of being infected by the virus, such as homosexual men. According to the Health Council, the pill is medically- and cost effective and should be considered "essential care" for high risk groups, NOS reports.
The Health Council looked into Prep at the request of former Health Minister Edith Schippers.
Municipal health service GGD Amsterdam is taking part in an international scientific study in which a new HIV prevention pill will be tested on humans. The aim is to find out whether experimental drug F/TAF is safe and effective in preventing HIV infection in healthy adults. Gay men and transgender women who have sex with men who are interested in participating in this study, can register with GGD Amsterdam until March 26th, AT5 reports.
The new HIV inhibitor Prep is in high demand among gay men living in the capital. GGD Amsterdam recently announced a trial on the pill that reduces the risk of HIV infection. Only 370 men can participate in the study, but the number of applications were much higher.
GGD Amsterdam has launched a medical study on Prep - a pill that can prevent infection with HIV - among gay men and transgenders. Those interested in joining the study can apply on the GGD Amsterdam website, Soa Aids Nederland reports.